Banner
Browse by multiple fields below

Download csv Download xlsx
PDX ID Sample ID Patient Id Sample Site Sample Source Age Sample Collected PSA at diagnosis (ng/mL) Gleason Score Primary Gleason Score Secondary Gleason Score Grade Group Tumour Grade D'Amico Risk Classification Primary Tumour Volume (cc) Treatment Prior to Specimen Collection PDX Host Type PDX Graft Site Current PDX Generation Average PDX Generation Time (days ± SEM) Tumour preparation2 Pubmed ID
426M 426M 426/452 Lung Surgery 25-29 NA 0.0 PRRT LuTate and Y-Tate, Octreotide Testosterone supplemented Subcutaneous 6 83 ± 5 Tumor solid 34413304
426M Cx 426M 426/452 Lung Surgery 25-29 NA 0.0 PRRT LuTate and Y-Tate, Octreotide Castrate Subcutaneous 9 (5*) 138 ± 9 Tumor solid 34413304
452C 452C 426/452 Prostate Transurethral resection of the prostate 25-29 NA 0.0 PRRT LuTate and Y-Tate, Octreotide Testosterone supplemented Subcutaneous 6 87 ± 11 Tumor solid 34413304
27.1A 27.1A 27 Brain Autopsy 70-74 42 0.0 ADT, docetaxel, abiraterone Testosterone supplemented Subcutaneous 24 84 ± 4 Tumor solid 34413304; 30049486
27.1A Cx 27.1A 27 Brain Autopsy 70-74 42 0.0 ADT, docetaxel, abiraterone Castrate Subcutaneous 29 (8*) 82 ± 8 Tumor solid 34413304; 30049486
27.2A 27.2A 27 Inguinal lymph node Autopsy 70-74 42 0.0 ADT, docetaxel, abiraterone Testosterone supplemented Subcutaneous 31 53 ± 6 Tumor solid 34413304; 30049486
27.2A Cx 27.2A 27 Inguinal lymph node Autopsy 70-74 42 0.0 ADT, docetaxel, abiraterone Castrate Subcutaneous 23 (4*) 81 ± 9 Tumor solid 34413304; 30049486
197M 197M 197/238 Spine Surgery 27.5 0.0 Zoladex, ketoconazole, docetaxel, prednisolone, zoledronate, abiraterone, radiotherapy Testosterone supplemented Renal 6 183 ± 20 Tumor solid 34413304